|
olaparib combined with trastuzumab and pertuzumab Clinical Trials
1 actively recruiting trial
Pipeline
Phase 4: 1
Top Sponsors
- Wen-Ming Cao1
Indications
- Elderly Females1
- HER2 + Breast Cancer1
- Breast Cancer1
- Neoadjuvant Therapy1
- Cancer1
Other1 trial
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.